Skip to main content
Equibles
IKT $2.41 +0.00%
IKT logo

IKT · Inhibikase Therapeutics, Inc.

Track IKT — free

Use IKT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about IKT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.41 +0.00 (+0.00%) At close · Aug 14
Market Cap
$336.28M
Shares
139.54M
All earnings calls

Earnings call · FY2021 Q1

Inhibikase Therapeutics, Inc. Q1 FY2021 Earnings Call

Inhibikase Therapeutics, Inc. Q1 FY2021 Earnings Call

Concluded Apr 1, 2021
Apr 1, 2021 0 turns
Period
FY2021 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $1.41M +419.7% YoY
Net income -$2.64M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Apr 1, 2021 10-Q report Filed May 17, 2021
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)